✦ LIBER ✦

GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study

✍ Scribed by Goodman, A. D.; Rossman, H.; Bar-Or, A.; Miller, A.; Miller, D. H.; Schmierer, K.; Lublin, F.; Khan, O.; Bormann, N. M.; Yang, M.; Panzara, M. A.; Sandrock, A. W.

Book ID: 119941161
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 408 KB
Volume: 72
Category: Article
ISSN: 0028-3878
DOI: 10.1212/01.wnl.0000343880.13764.69

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elagolix Treatment for Endometriosis-Ass

Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

✍ Diamond, M. P.; Carr, B.; Dmowski, W. P.; Koltun, W.; O'Brien, C.; Jiang, P.; Bu 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 436 KB

Phase III, randomized, double-blind, pla

Phase III, randomized, double-blind, placebo-controlled trial of topical 2

✍ Coudert, Amélie E; Ostertag, Agnès; Baaroun, Vanessa; Artaud, Catherine; Ifi-Nau 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 192 KB

Efficacy and Safety of AMG 853 in Asthma

Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

✍ Busse, W.W.; Wenzel, S.E.; Meltzer, E.O.; Kerwin, E.M.; Liu, M.C.; Zhang, N.; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A pilot double-blind randomized placebo-

A pilot double-blind randomized placebo-controlled study of molsidomine 16

✍ Roger Messin; Tamas Fenyvesi; Fabienne Carreer-Bruhwyler; Jacques Crommen; Patri 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 219 KB

Polyunsaturated fatty acids and depressi

Polyunsaturated fatty acids and depression: Preliminary results of a randomized double blind placebo controlled study

✍ M. Pomponi; S. Lippa; R. Natili; M. Di Nicola; C. Ciciarelli; M. Mazza; C. Ville 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB

A phase 2, randomized, double-blind, pla

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis

✍ Vlad Ratziu; Muhammad Y. Sheikh; Arun J. Sanyal; Joseph K. Lim; Hari Conjeevaram 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

In nonalcoholic steatohepatitis (NASH), the extent of hepatocyte apoptosis correlates with disease severity. Reducing hepatocyte apoptosis with the selective caspase inhibitor GS-9450 has a potential for altering the course of the liver disease. In this phase 2, double-blind study, 124 subjects with